Literature DB >> 3494886

Complement activation during major operations with or without cardiopulmonary bypass.

E Fosse, T E Mollnes, B Ingvaldsen.   

Abstract

Plasma concentrations of the complement products C3dg and the terminal complement complex, as well as the number of granulocytes (polymorphonuclear neutrophils), were assessed in patients undergoing aorta-coronary bypass with extracorporeal circulation, abdominal aneurysmectomy with implantation of an aortic graft, or thoracotomy without the introduction of synthetic material into the circulation. The concentration of terminal complement complex increased significantly only in the group undergoing extracorporeal circulation, with a corresponding drop in the number of granulocytes. In contrast, the C3dg concentration increased during both extracorporeal circulation and abdominal aneurysmectomy, which indicates that other factors than extracorporeal circulation may affect C3 activation during major operations. In the thoracotomy group, where the most pronounced increase in granulocytes was found, no complement activation was recorded. It is concluded that extracorporeal circulation activates the terminal pathway of complement and that assays detecting activation of both the initial and the terminal parts should be included when the pathophysiology of complement is examined during major operations and extracorporeal circulation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3494886

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  12 in total

1.  Complement activation and bioincompatibility. The terminal complement complex for evaluation and surface modification with heparin for improvement of biomaterials.

Authors:  T E Mollnes; V Videm; J Riesenfeld; P Garred; J L Svennevig; E Fosse; K Hogasen; M Harboe
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

Review 2.  Functions and relevance of the terminal complement sequence.

Authors:  S Bhakdi; F Hugo; J Tranum-Jensen
Journal:  Blut       Date:  1990-06

3.  Urine complement activation fragments are increased in patients with kidney injury after cardiac surgery.

Authors:  Jennifer Laskowski; Heather Thiessen Philbrook; Chirag R Parikh; Joshua M Thurman
Journal:  Am J Physiol Renal Physiol       Date:  2019-07-17

Review 4.  The impact of heparin compounds on cellular inflammatory responses: a construct for future investigation and pharmaceutical development.

Authors:  Essam Elsayed; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2003-02       Impact factor: 2.300

5.  The Complement System Component C5a Produces Thermal Hyperalgesia via Macrophage-to-Nociceptor Signaling That Requires NGF and TRPV1.

Authors:  Leonid P Shutov; Charles A Warwick; Xiaoyu Shi; Aswini Gnanasekaran; Andrew J Shepherd; Durga P Mohapatra; Trent M Woodruff; J David Clark; Yuriy M Usachev
Journal:  J Neurosci       Date:  2016-05-04       Impact factor: 6.167

6.  Evidence for iC3 generation during cardiopulmonary bypass as the result of blood-gas interaction.

Authors:  M Pekna; L Nilsson; K Nilsson-Ekdahl; U R Nilsson; B Nilsson
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

7.  In vivo clearance studies of the terminal fluid-phase complement complex in rabbits.

Authors:  F Hugo; C Berstecher; S Krämer; W Fassbender; S Bhakdi
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

8.  High-sensitivity C-reactive protein (hs-CRP) and tumor necrotizing factor-alpha (TNF-alpha) after on- and off- pump coronary artery bypass grafting.

Authors:  H Javadzadegan; N Nezami; K Ghobadi; A Sadighi; A A Abolfathi; N D Nader
Journal:  HSR Proc Intensive Care Cardiovasc Anesth       Date:  2010

9.  Increased local concentration of complement C5a contributes to incisional pain in mice.

Authors:  Jun H Jang; Deyong Liang; Kanta Kido; Yuan Sun; David J Clark; Timothy J Brennan
Journal:  J Neuroinflammation       Date:  2011-07-07       Impact factor: 8.322

10.  Role of cytokines in myocardial ischemia and reperfusion.

Authors:  H S Sharma; D K Das
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.